← Back to all stories
FDA Approves Groundbreaking Treatment Targeting the Root Cause of Narcolepsy Type-1
Photo: Pharmacy Images / Unsplash
In a major medical milestone, the US FDA has approved the first-ever drug designed to treat the underlying cause of narcolepsy type-1 rather than just managing its symptoms. This breakthrough therapy offers new hope and improved quality of life for the estimated 120,000 Americans living with the chronic sleep disorder.
In a major medical milestone, the US FDA has approved the first-ever drug designed to treat the underlying cause of narcolepsy type-1 rather than just managing its symptoms. This breakthrough therapy offers new hope and improved quality of life for the estimated 120,000 Americans living with the chronic sleep disorder.